Sickle cell trait does not cause "sickle cell crisis" leading to exertion-related death: a systematic review.

IF 23.1 1区 医学 Q1 HEMATOLOGY Blood Pub Date : 2025-03-27 DOI:10.1182/blood.2024026899
Lachelle D Weeks, Allecia M Wilson, Rakhi P Naik, Yvonne Efebera, M Hassan Murad, Anjlee Mahajan, Patrick T McGann, Madeleine Verhovsek, Angela C Weyand, Ahmar U Zaidi, Michael R DeBaun, Chancellor Donald, Roger A Mitchell
{"title":"Sickle cell trait does not cause \"sickle cell crisis\" leading to exertion-related death: a systematic review.","authors":"Lachelle D Weeks, Allecia M Wilson, Rakhi P Naik, Yvonne Efebera, M Hassan Murad, Anjlee Mahajan, Patrick T McGann, Madeleine Verhovsek, Angela C Weyand, Ahmar U Zaidi, Michael R DeBaun, Chancellor Donald, Roger A Mitchell","doi":"10.1182/blood.2024026899","DOIUrl":null,"url":null,"abstract":"<p><strong>Abstract: </strong>Globally, an estimated 300 million individuals have sickle cell trait (SCT), the carrier state for sickle cell disease (SCD). Although SCD is associated with increased morbidity and shortened life span, SCT has a life span comparable with that of the general population. However, \"sickle cell crisis\" has been used as a cause of death for decedents with SCT in reports of exertion-related death in athletes, military personnel, and individuals in police custody. To appraise this practice, the American Society of Hematology convened an expert panel of hematologists and forensic pathologists to conduct a systematic review of the literature relating to the occurrence of sickle cell pain crises and exertion-related mortality in people with SCT. Multiple bibliographic databases were searched with controlled vocabulary and keywords related to \"sickle cell trait,\" \"vaso-occlusive pain,\" and \"death,\" yielding 18 of 1474 citations. Independent pairs of reviewers selected studies and extracted data. We found no studies comparing uncomplicated acute pain crises in individuals with SCT and SCD. Additionally, no study was identified to support the occurrence of acute vaso-occlusive pain crises in individuals with SCT. Furthermore, this systematic review did not identify any evidence to support an association between SCT and sudden unexplained death in the absence of exertion-related rhabdomyolysis. We conclude that there are no data to support the diagnosis of acute vaso-occlusive sickle cell crisis as a cause of death in SCT, nor does the available evidence support the use of SCT as a cause of exertion-related death without rhabdomyolysis.</p>","PeriodicalId":9102,"journal":{"name":"Blood","volume":" ","pages":"1345-1352"},"PeriodicalIF":23.1000,"publicationDate":"2025-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Blood","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1182/blood.2024026899","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Abstract: Globally, an estimated 300 million individuals have sickle cell trait (SCT), the carrier state for sickle cell disease (SCD). Although SCD is associated with increased morbidity and shortened life span, SCT has a life span comparable with that of the general population. However, "sickle cell crisis" has been used as a cause of death for decedents with SCT in reports of exertion-related death in athletes, military personnel, and individuals in police custody. To appraise this practice, the American Society of Hematology convened an expert panel of hematologists and forensic pathologists to conduct a systematic review of the literature relating to the occurrence of sickle cell pain crises and exertion-related mortality in people with SCT. Multiple bibliographic databases were searched with controlled vocabulary and keywords related to "sickle cell trait," "vaso-occlusive pain," and "death," yielding 18 of 1474 citations. Independent pairs of reviewers selected studies and extracted data. We found no studies comparing uncomplicated acute pain crises in individuals with SCT and SCD. Additionally, no study was identified to support the occurrence of acute vaso-occlusive pain crises in individuals with SCT. Furthermore, this systematic review did not identify any evidence to support an association between SCT and sudden unexplained death in the absence of exertion-related rhabdomyolysis. We conclude that there are no data to support the diagnosis of acute vaso-occlusive sickle cell crisis as a cause of death in SCT, nor does the available evidence support the use of SCT as a cause of exertion-related death without rhabdomyolysis.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
镰状细胞特性不会导致“镰状细胞危象”导致运动相关死亡:一项系统综述。
在全球范围内,估计有3亿人患有镰状细胞特征(SCT),这是镰状细胞病的携带者状态。虽然镰状细胞病(SCD)与发病率增加和寿命缩短有关,但SCT的寿命与普通人群相当。然而,在运动员、军事人员和被警察拘留的个人的运动相关死亡报告中,“镰状细胞危象”被用作SCT患者的死亡原因。为了评估这种做法,美国血液学会(ASH)召集了一个由血液学家和法医病理学家组成的专家小组,对SCT患者镰状细胞疼痛危象和劳累相关死亡率的相关文献进行了系统回顾。在多个文献数据库中检索了与“镰状细胞特征”、“血管闭塞性疼痛”和“死亡”相关的受控词汇和关键词,在1474条引文中检索了18条。独立的审稿人对选择研究和提取数据。我们没有发现比较SCT和SCD患者无并发症急性疼痛危象的研究。此外,没有研究证实SCT患者发生急性血管闭塞性疼痛危像。此外,本系统综述未发现任何证据支持在没有劳力相关性横纹肌溶解的情况下SCT与突然不明原因死亡之间的关联。我们的结论是,没有数据支持急性血管闭塞性镰状细胞危象作为SCT死亡原因的诊断,也没有现有证据支持使用SCT作为无横纹肌溶解的运动相关死亡的原因。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Blood
Blood 医学-血液学
CiteScore
23.60
自引率
3.90%
发文量
955
审稿时长
1 months
期刊介绍: Blood, the official journal of the American Society of Hematology, published online and in print, provides an international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology. Primary research articles will be published under the following scientific categories: Clinical Trials and Observations; Gene Therapy; Hematopoiesis and Stem Cells; Immunobiology and Immunotherapy scope; Myeloid Neoplasia; Lymphoid Neoplasia; Phagocytes, Granulocytes and Myelopoiesis; Platelets and Thrombopoiesis; Red Cells, Iron and Erythropoiesis; Thrombosis and Hemostasis; Transfusion Medicine; Transplantation; and Vascular Biology. Papers can be listed under more than one category as appropriate.
期刊最新文献
IDH2 Clonal Hematopoiesis and IKAROS Loss Cooperate in a B-ALL Subtype after Lenalidomide Therapy for Multiple Myeloma. Radiotherapy for indolent primary cutaneous B-cell lymphoma: an international multicenter ILROG analysis. TMEM187 is a novel modulator in the regulation of erythropoiesis. Defective cerebrovascular development in mice lacking TFPI is restored by activated protein C. A niche for every stem cell in myeloproliferative neoplasms.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1